Rebounding stocks: Keryx Biopharmaceuticals (NASDAQ:KERX), MGIC Investment Corp. (NYSE:MTG), Boston Scientific Corporation (NYSE:BSX)

Posted by Ryan Mandell April 22, 2013 0 Comment 756 views

Northern, WI 04/22/2013 (GDPInsider) –  Keryx Biopharmaceuticals (NASDAQ:KERX) started the day’s trading session with a value of $8.06, a very modest jump on the previous close of $8.03. The stock is currently trading up at 5.59% and the volume is 3.39 million shares. The day’s trading range is $8.06 and $8.64. The day’s spread in share value means that KERX is down 14.63% on its 52-week high but up a whopping 535.82% on its 52-week low. The stock’s technical chart is trending northwards and current trading values puts the stock 18.90% above its 50-day moving average. It’s a solid 121.23% up on the 200-day moving average and EPS next year is tipped to rise by 108%.

Is KERX a solid investment at these levels? Get exclusive data and trends here.

MGIC Investment Corp. (NYSE:MTG) opened the day’s trading at $5.04 and is presently down 1.70%. The day’s range is $4.86 and $5.10 and this translates into a 640.91% increase on the 52-week low and a 21% drop on the stock’s 52-week high. The stock is down 0.90% on its 20-day moving average but up 15.22% and 90.86% on its 50-day and 200-day moving averages respectively. Outlook for the stock is positive where EPS is concerned and analysts expect this to jump next year by 124%. The stock has a forward PE of 27.72 and there are 200.45 million shares outstanding.

 How Should Investors Trade MTG Now? Check out this exclusive report!

Boston Scientific Corporation (NYSE:BSX) opened trading at $7.26 and is currently down 0.28%. Trading volume for BSX is 4.49 million shares and the day’s range is $7.169 and $7.30. The stock has a RSI of 40.46 and the technical chart data shows a southward slope for since the start of April 2013. The stock is down 4.69% on its 20-day moving average and is also down 3.43% on its 50-day moving average. EPS this year is expected to drop by 1096.10% and insider transactions for BSX has increased by 67.77%. The company has sales of $7.25 billion and a market cap of $9.82 billion.

How Should Investors Trade BSX Now? Get exclusive insights and updates here.

About Ryan Mandell

Ryan Mandell is our senior staff writer covering the White House for Political Report, Ryan also coordinates with the main newsroom news items and contributing write-ups on cultural, social and political activities. Ryan holds an undergraduate degree in journalism, a Doctorate in international relations and a Master Degree in mass communications with an emphasis in print journalism. Ryan also covered the International Society of Social Defense congress in Spain in 2007 and taken part in the Global Forum on economic policies

View all post by Ryan Mandell Visit author's website

Write Your Comment